2016 annual financial data
Viking Therapeutics 2016 Operating margin
Viking Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,847,275 USD and net income was -14,731,822 USD.
Operating cash flow was -11,071,263 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,847,275 USD
- Net income
- -14,731,822 USD
- Operating cash flow
- -11,071,263 USD